Pasithea Therapeutics Corp.

KTTA

—

Advanced chart & tools →

Pasithea Therapeutics Corp.KTTA

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.91

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$486,559

Net income

$-20.43M

Net margin

-4198.4%

Gross margin

-0.5%

Dividends & financials

Pasithea Therapeutics Corp. (KTTA) reported revenue of $486,559 and net income of $-20.43M, or $-2.91 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.